Back to search
Citrate Transporter Deficiency
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Citrate Transporter Deficiency trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Citrate Transporter Deficiency trials you may qualify forPhase 1/2, open-label study to assess the efficacy and safety of a single lumbar intrathecal administration of TSHA-105 in individuals with SLC13A5 Citrate Tran…
SLC13A5 deficiency (Citrate Transporter Disorder, EIEE 25) is a rare genetic disorder with neurodevelopmental delays and seizure onset in the first few days of…
SLC13A5 deficiency (Citrate Transporter Disorder, EIEE 25) is a rare genetic disorder with neurodevelopmental delays and seizure onset in the first few days of…
The purpose of this trial is to determine if an alternative energy source will impact brain metabolism in a disorder characterized by glucose metabolism failure…
The purpose of this study is to determine whether triheptanoin (UX007) is effective in the treatment of neurological symptoms related to citrate transporter def…